{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:09:19Z","timestamp":1793138959057,"version":"4.5.0"},"reference-count":91,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,19]],"date-time":"2017-10-19T00:00:00Z","timestamp":1508371200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003246","name":"Netherlands Organisation for Scientific Research","doi-asserted-by":"publisher","award":["VICI 91814650"],"award-info":[{"award-number":["VICI 91814650"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche (ANR)","doi-asserted-by":"publisher","award":["11-IDEX-005-02"],"award-info":[{"award-number":["11-IDEX-005-02"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002915","name":"(FRM","doi-asserted-by":"publisher","award":["DEQ20140329531"],"award-info":[{"award-number":["DEQ20140329531"]}],"id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]},{"name":"ARC","award":["PDF20100601037"],"award-info":[{"award-number":["PDF20100601037"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.autrev.2017.10.009","type":"journal-article","created":{"date-parts":[[2017,10,14]],"date-time":"2017-10-14T17:03:03Z","timestamp":1508000583000},"page":"1246-1253","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":300,"title":["New insights in the pathogenesis of immunoglobulin A vasculitis (Henoch-Sch\u00f6nlein purpura)"],"prefix":"10.1016","volume":"16","author":[{"given":"Marieke H.","family":"Heineke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aranka V.","family":"Ballering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Jamin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanae","family":"Ben Mkaddem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato C.","family":"Monteiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjolein","family":"Van Egmond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2017.10.009_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised international chapel hill consensus conference nomenclature of vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.10.009_bb0010","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/BOR.0b013e32835d8e2a","article-title":"Epidemiology of immunoglobulin A vasculitis (Henoch-Schonlein): current state of knowledge","volume":"25","author":"Piram","year":"2013","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2017.10.009_bb0015","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1097\/SMJ.0b013e3180f62d0f","article-title":"Henoch-Schonlein purpura: a review article","volume":"100","author":"Roberts","year":"2007","journal-title":"South Med J"},{"key":"10.1016\/j.autrev.2017.10.009_bb0020","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/S0140-6736(02)11279-7","article-title":"Incidence of Henoch-Schonlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins","volume":"360","author":"Gardner-Medwin","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2017.10.009_bb0025","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1046\/j.1523-1755.2001.059003823.x","article-title":"What is the difference between IgA nephropathy and Henoch-Schonlein purpura nephritis?","volume":"59","author":"Davin","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2017.10.009_bb0030","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/imr.12337","article-title":"The era of the immunoglobulin A Fc receptor FcalphaRI; its function and potential as target in disease","volume":"268","author":"Aleyd","year":"2015","journal-title":"Immunol Rev"},{"key":"10.1016\/j.autrev.2017.10.009_bb0035","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/path.1877","article-title":"The function of immunoglobulin A in immunity","volume":"208","author":"Woof","year":"2006","journal-title":"J Pathol"},{"issue":"132","key":"10.1016\/j.autrev.2017.10.009_bb0040","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4049\/jimmunol.132.1.16","article-title":"Distribution of IgA1-, IgA2-, and J chain-containing cells in human tissues","author":"Crago","year":"1984","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2017.10.009_bb0045","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.4049\/jimmunol.167.5.2861","article-title":"Human IgA activates the complement system via the mannan-binding lectin pathway","volume":"167","author":"Roos","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2017.10.009_bb0050","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/eji.1830170304","article-title":"Activation of the alternative pathway of complement by human serum IgA","volume":"17","author":"Hiemstra","year":"1987","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2017.10.009_bb0055","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1084\/jem.194.4.417","article-title":"Identification of the transferrin receptor as a novel immunoglobulin (Ig)A1 receptor and its enhanced expression on mesangial cells in IgA nephropathy","volume":"194","author":"Moura","year":"2001","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2017.10.009_bb0060","doi-asserted-by":"crossref","first-page":"5806","DOI":"10.4049\/jimmunol.163.11.5806","article-title":"Crosslinking of the human Fc receptor for IgA (FcalphaRI\/CD89) triggers FcR gamma-chain-dependent shedding of soluble CD89","volume":"163","author":"van Zandbergen","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2017.10.009_bb0065","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1600-065X.2009.00832.x","article-title":"Inhibitory ITAMs as novel regulators of immunity","volume":"232","author":"Blank","year":"2009","journal-title":"Immunol Rev"},{"key":"10.1016\/j.autrev.2017.10.009_bb0070","first-page":"31","article-title":"Identification of FcalphaRI as an inhibitory receptor that controls inflammation: dual role of FcRgamma ITAM","volume":"22","author":"Pasquier","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2017.10.009_bb0075","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.autrev.2012.10.011","article-title":"Anti-inflammatory role of the IgA Fc receptor (CD89): from autoimmunity to therapeutic perspectives","volume":"12","author":"Ben Mkaddem","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.10.009_bb0080","article-title":"Immunoglobulin A: magic bullet or Trojan horse?","author":"Heineke","year":"2016","journal-title":"Eur J Clin Investig"},{"key":"10.1016\/j.autrev.2017.10.009_bb0085","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.4049\/jimmunol.1300261","article-title":"IgA enhances NETosis and release of neutrophil extracellular traps by polymorphonuclear cells via Fcalpha receptor I","volume":"192","author":"Aleyd","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2017.10.009_bb0090","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1053\/j.gastro.2009.06.047","article-title":"Immunoglobulin A: Fc(alpha)RI interactions induce neutrophil migration through release of leukotriene B4","volume":"137","author":"van der Steen","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2017.10.009_bb0095","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.4049\/jimmunol.1502353","article-title":"IgA complexes in plasma and synovial fluid of patients with rheumatoid arthritis induce neutrophil extracellular traps via FcalphaRI","volume":"197","author":"Aleyd","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2017.10.009_bb0100","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.4049\/jimmunol.1101763","article-title":"Blocking Fcalpha receptor I on granulocytes prevents tissue damage induced by IgA autoantibodies","volume":"189","author":"van der Steen","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2017.10.009_bb0105","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00467-009-1230-x","article-title":"Pathogenesis of Henoch-Sch\u00f6nlein purpura nephritis","volume":"25","author":"Lau","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.autrev.2017.10.009_bb0110","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000382134","article-title":"New insights into the pathogenesis of IgA nephropathy","volume":"1","author":"Novak","year":"2015","journal-title":"Kidney Dis"},{"key":"10.1016\/j.autrev.2017.10.009_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.it.2017.02.004","article-title":"The immunoregulatory roles of antibody glycosylation","author":"Jennewein","year":"2017","journal-title":"Trends Immunol"},{"key":"10.1016\/j.autrev.2017.10.009_bb0120","doi-asserted-by":"crossref","first-page":"5330","DOI":"10.1074\/jbc.M113.512277","article-title":"Cytokines alter IgA1 O-glycosylation by dysregulating C1GalT1 and ST6GalNAc-II enzymes","volume":"289","author":"Suzuki","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2017.10.009_bb0125","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/ki.1997.361","article-title":"Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG","volume":"52","author":"Tomana","year":"1997","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2017.10.009_bb0130","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1172\/JCI5535","article-title":"Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies","volume":"104","author":"Tomana","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2017.10.009_bb0135","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/ki.2011.16","article-title":"Aberrant glycosylation of IgA1 is inherited in pediatric IgA nephropathy and Henoch-Sch\u00f6nlein purpura nephritis","volume":"80","author":"Kiryluk","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2017.10.009_bb0140","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1093\/ndt\/13.4.930","article-title":"Abnormal IgA glycosylation in Henoch-Sch\u00f6nlein purpura restricted to patients with clinical nephritis","volume":"13","author":"Allen","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.autrev.2017.10.009_bb0145","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1007\/s00467-007-0623-y","article-title":"Serum levels of galactose-deficient IgA in children with IgA nephropathy and Henoch-Sch\u00f6nlein purpura","volume":"22","author":"Lau","year":"2007","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.autrev.2017.10.009_bb0150","series-title":"Book Aberrant Glycosylation of IgA1 and Anti-glycan Antibodies in IgA Nephropathy: Role of Mucosal Immune System","first-page":"60","article-title":"Aberrant glycosylation of IgA1 and anti-glycan antibodies in IgA nephropathy: role of mucosal immune system","author":"Novak","year":"2011"},{"key":"10.1016\/j.autrev.2017.10.009_bb0155","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1056\/NEJMra1206793","article-title":"IgA nephropathy","volume":"368","author":"Wyatt","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2017.10.009_bb0160","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1084\/jem.191.11.1999","article-title":"Fcalpha receptor (CD89) mediates the development of immunoglobulin A (IgA) nephropathy (Berger's disease). Evidence for pathogenic soluble receptor-Iga complexes in patients and CD89 transgenic mice","volume":"191","author":"Launay","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2017.10.009_bb0165","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1038\/ki.2011.276","article-title":"Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases","volume":"80","author":"Tissandie","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2017.10.009_bb0170","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1038\/ki.2010.314","article-title":"Association of soluble CD89 levels with disease progression but not susceptibility in IgA nephropathy","volume":"78","author":"Vuong","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2017.10.009_bb0175","doi-asserted-by":"crossref","DOI":"10.1038\/ki.2015.94","article-title":"Gluten exacerbates IgA nephropathy in humanized mice through gliadin-CD89 interaction","author":"Papista","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2017.10.009_bb0180","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3389\/fimmu.2016.00117","article-title":"The origin and activities of IgA1-containing immune complexes in IgA nephropathy","volume":"7","author":"Knoppova","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2017.10.009_bb0185","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000422410","article-title":"Defective galactosylation and clearance of IgA1 molecules as a possible etiopathogenic factor in IgA nephropathy","volume":"104","author":"Mestecky","year":"1993","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.autrev.2017.10.009_bb0190","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/intimm\/dxr125","article-title":"Integrin alpha1\/beta1 and alpha2\/beta1 as a receptor for IgA1 in human glomerular mesangial cells in IgA nephropathy","volume":"24","author":"Kaneko","year":"2012","journal-title":"Int Immunol"},{"key":"10.1016\/j.autrev.2017.10.009_bb0195","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1681\/ASN.V9112048","article-title":"Protective role of IgA1 glycans against IgA1 self-aggregation and adhesion to extracellular matrix proteins","volume":"9","author":"Kokubo","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2017.10.009_bb0200","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1084\/jem.20112005","article-title":"Transglutaminase is essential for IgA nephropathy development acting through IgA receptors","volume":"209","author":"Berthelot","year":"2012","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2017.10.009_bb0205","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1523-1755.2005.67107.x","article-title":"IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells","volume":"67","author":"Novak","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2017.10.009_bb0210","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1093\/ndt\/gfr448","article-title":"IgA1 immune complexes from pediatric patients with IgA nephropathy activate cultured human mesangial cells","volume":"26","author":"Novak","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.autrev.2017.10.009_bb0215","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000102455","article-title":"IgA nephropathy and Henoch-Schoenlein purpura nephritis: aberrant glycosylation of IgA1, formation of IgA1-containing immune complexes, and activation of mesangial cells","volume":"157","author":"Novak","year":"2007","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.autrev.2017.10.009_bb0220","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1038\/ki.2009.71","article-title":"Macromolecular IgA1 taken from patients with familial IgA nephropathy or their asymptomatic relatives have higher reactivity to mesangial cells in vitro","volume":"75","author":"Tam","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2017.10.009_bb0225","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000423876","article-title":"Potential factors governing extracellular matrix production by mesangial cells: their relevance for the pathogenesis of IgA nephropathy","volume":"111","author":"Gomez-Guerrero","year":"1995","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.autrev.2017.10.009_bb0230","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.rinim.2012.08.002","article-title":"In vitro-generated immune complexes containing galactose-deficient IgA1 stimulate proliferation of mesangial cells","volume":"2","author":"Yanagihara","year":"2012","journal-title":"Res Immunol"},{"key":"10.1016\/j.autrev.2017.10.009_bb0235","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/ki.2012.197","article-title":"The level of galactose-deficient IgA1 in the sera of patients with IgA nephropathy is associated with disease progression","volume":"82","author":"Zhao","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2017.10.009_bb0240","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1038\/sj.ki.5002185","article-title":"Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels","volume":"71","author":"Moldoveanu","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2017.10.009_bb0245","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/01.ASN.0000046961.04917.83","article-title":"Enhanced expression of the CD71 mesangial IgA1 receptor in Berger disease and Henoch-Sch\u00f6nlein nephritis: association between CD71 expression and IgA deposits","volume":"14","author":"Haddad","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2017.10.009_bb0250","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.molimm.2013.05.219","article-title":"Differential expression of functional Fc-receptors and additional immune complex receptors on mouse kidney cells","volume":"56","author":"Suwanichkul","year":"2013","journal-title":"Mol Immunol"},{"key":"10.1016\/j.autrev.2017.10.009_bb0255","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1093\/ndt\/gfs445","article-title":"Deposition of IgA in primary IgA nephropathy: it takes at least four to tango","volume":"28","author":"Daha","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.autrev.2017.10.009_bb0260","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/S0140-6736(79)92505-4","article-title":"IgA immune complexes in Henoch-Schonlein purpura","volume":"2","author":"Levinsky","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2017.10.009_bb0265","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.autrev.2016.12.012","article-title":"Anti-endothelial cell antibodies in vasculitis: a systematic review","volume":"16","author":"Legendre","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.10.009_bb0270","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1046\/j.1365-2249.2002.01964.x","article-title":"The level of IgA antibodies to human umbilical vein endothelial cells can be enhanced by TNF-\u03b1 treatment in children with Henoch\u2013Sch\u00f6nlein purpura","volume":"130","author":"Yang","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2017.10.009_bb0275","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/j.1365-2133.2012.11068.x","article-title":"Identification and characterization of IgA antibodies against \u03b22-glycoprotein I in childhood Henoch\u2013Sch\u00f6nlein purpura","volume":"167","author":"Yang","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2017.10.009_bb0280","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/art.1780400322","article-title":"Endothelial cells as target for antiphospholipid antibodies. Human polyclonal and monoclonal anti-beta 2-glycoprotein I antibodies react in vitro with endothelial cells through adherent beta 2-glycoprotein I and induce endothelial activation","volume":"40","author":"Del Papa","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.10.009_bb0285","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/j.1365-2133.2006.07457.x","article-title":"Elevated serum IgA anticardiolipin antibody levels in adult Henoch-Schonlein purpura","volume":"155","author":"Kawakami","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2017.10.009_bb0290","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/art.23528","article-title":"High titer of serum antiphospholipid antibody levels in adult Henoch-Schonlein purpura and cutaneous leukocytoclastic angiitis","volume":"59","author":"Kawakami","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.10.009_bb0295","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0190-9622(94)70246-2","article-title":"IgA anticardiolipin antibodies associated with Henoch-Schonlein purpura","volume":"31","author":"Burden","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2017.10.009_bb0300","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1046\/j.1365-2249.2000.01361.x","article-title":"Increased transforming growth factor-beta (TGF-beta)-secreting T cells and IgA anti-cardiolipin antibody levels during acute stage of childhood Henoch-Schonlein purpura","volume":"122","author":"Yang","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2017.10.009_bb0305","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1136\/adc.78.3.240","article-title":"Soluble thrombomodulin and antibodies to bovine glomerular endothelial cells in patients with Henoch-Schonlein purpura","volume":"78","author":"Fujieda","year":"1998","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.autrev.2017.10.009_bb0310","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1136\/ard.2005.035295","article-title":"Antiendothelial cell antibodies in vasculitis and connective tissue disease","volume":"65","author":"Belizna","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.10.009_bb0315","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1136\/ard.2003.016196","article-title":"Sera from children with active Henoch-Sch\u00f6nlein purpura can enhance the production of interleukin 8 by human umbilical venous endothelial cells","volume":"63","author":"Yang","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.10.009_bb0320","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1365-2249.2006.03076.x","article-title":"Circulating IgA from acute stage of childhood Henoch-Sch\u00f6nlein purpura can enhance endothelial interleukin (IL)-8 production through MEK\/ERK signalling pathway","volume":"144","author":"Yang","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2017.10.009_bb0325","doi-asserted-by":"crossref","first-page":"456","DOI":"10.3109\/03009749709065719","article-title":"The role of cytokines in Henoch Schonlein purpura","volume":"26","author":"Besbas","year":"1997","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2017.10.009_bb0330","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1002\/eji.201141982","article-title":"Enhanced FcalphaRI-mediated neutrophil migration towards tumour colonies in the presence of endothelial cells","volume":"42","author":"Otten","year":"2012","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2017.10.009_bb0335","article-title":"The interaction between circulating complement proteins and cutaneous microvascular endothelial cells in the development of childhood Henoch-Sch\u00f6nlein purpura","volume":"10","author":"Yang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2017.10.009_bb0340","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.imbio.2016.06.112","article-title":"Variants in complement factor H affect complement activation in Henoch\u2013Schonlein purpura nephritis","volume":"10","author":"Guo","year":"2016","journal-title":"Immunobiology"},{"key":"10.1016\/j.autrev.2017.10.009_bb0345","doi-asserted-by":"crossref","DOI":"10.1681\/ASN.2015010012","article-title":"Rare variants in the complement factor H\u2013related protein 5 gene contribute to genetic susceptibility to IgA nephropathy","author":"Zhai","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2017.10.009_bb0350","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1053\/j.ajkd.2004.10.020","article-title":"Activation of the lectin complement pathway in Henoch-Sch\u00f6nlein purpura nephritis","volume":"45","author":"Hisano","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.autrev.2017.10.009_bb0355","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1681\/ASN.2005090923","article-title":"Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease","volume":"17","author":"Roos","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2017.10.009_bb0360","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0272-6386(00)70192-2","article-title":"Complement activation through the lectin pathway in patients with Henoch-Sch\u00f6nlein purpura nephritis","volume":"35","author":"Endo","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.autrev.2017.10.009_bb0365","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1681\/ASN.2011070701","article-title":"O-glycosylated IgA rheumatoid factor induces IgA deposits and glomerulonephritis","volume":"23","author":"Otani","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2017.10.009_bb0370","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/RHU.0000000000000360","article-title":"Familial Henoch-Sch\u00f6nlein syndrome","volume":"22","author":"Ostini","year":"2016","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.autrev.2017.10.009_bb0375","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1007\/s00296-012-2661-4","article-title":"The genetics of Henoch\u2013Sch\u00f6nlein purpura: a systematic review and meta-analysis","volume":"33","author":"He","year":"2013","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2017.10.009_bb0380","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s13075-015-0622-5","article-title":"Association of HLA-B*41:02 with Henoch-Sch\u00f6nlein purpura (IgA vasculitis) in Spanish individuals irrespective of the HLA-DRB1 status","volume":"17","author":"L\u00f3pez-Mej\u00edas","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2017.10.009_bb0385","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2174\/138920207783591690","article-title":"The HLA region and autoimmune disease: associations and mechanisms of action","volume":"8","author":"Gough","year":"2007","journal-title":"Curr Genomics"},{"key":"10.1016\/j.autrev.2017.10.009_bb0390","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.autrev.2013.04.003","article-title":"Is there a crossroad between infections, genetics, and Henoch\u2013Sch\u00f6nlein purpura?","volume":"12","author":"Rigante","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.10.009_bb0395","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jfma.2012.12.007","article-title":"Chemokine MCP1\/CCL2 and RANTES\/CCL5 gene polymorphisms influence Henoch-Schonlein purpura susceptibility and severity","volume":"114","author":"Yu","year":"2015","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.autrev.2017.10.009_bb0400","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.autrev.2007.11.012","article-title":"The immunobiology of Henoch\u2013Sch\u00f6nlein purpura","volume":"7","author":"Yang","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.10.009_bb0405","doi-asserted-by":"crossref","first-page":"82","DOI":"10.5409\/wjcp.v5.i1.82","article-title":"Current views of the relationship between Helicobacter pylori and Henoch-Schonlein purpura in children","volume":"5","author":"Xiong","year":"2016","journal-title":"World J Clin Pediatr"},{"key":"10.1016\/j.autrev.2017.10.009_bb0410","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s12519-012-0373-1","article-title":"Is Helicobacter pylori infection associated with Henoch-Schonlein purpura in Chinese children? A meta-analysis","volume":"8","author":"Xiong","year":"2012","journal-title":"World J Pediatr"},{"key":"10.1016\/j.autrev.2017.10.009_bb0415","doi-asserted-by":"crossref","first-page":"751","DOI":"10.4103\/1319-2442.113871","article-title":"Immuno-histochemistry analysis of Helicobacter pylori antigen in renal biopsy specimens from patients with glomerulonephritis","volume":"24","author":"Li","year":"2013","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"10.1016\/j.autrev.2017.10.009_bb0420","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.bbrc.2014.01.050","article-title":"CagA, a major virulence factor of Helicobacter pylori, promotes the production and underglycosylation of IgA1 in DAKIKI cells","volume":"444","author":"Yang","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.autrev.2017.10.009_bb0425","doi-asserted-by":"crossref","first-page":"7792","DOI":"10.4049\/jimmunol.174.12.7792","article-title":"The influences of hinge length and composition on the susceptibility of human IgA to cleavage by diverse bacterial IgA1 proteases","volume":"174","author":"Senior","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2017.10.009_bb0430","doi-asserted-by":"crossref","first-page":"30964","DOI":"10.1038\/srep30964","article-title":"Bacterial IgA protease-mediated degradation of agIgA1 and agIgA1 immune complexes as a potential therapy for IgA nephropathy","volume":"6","author":"Wang","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2017.10.009_bb0435","doi-asserted-by":"crossref","DOI":"10.1681\/ASN.2015080856","article-title":"IgA1 protease treatment reverses mesangial deposits and hematuria in a model of IgA nephropathy","author":"Lechner","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2017.10.009_bb0440","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2353\/ajpath.2008.070131","article-title":"Microbial IgA protease removes IgA immune complexes from mouse glomeruli in vivo: potential therapy for IgA nephropathy","volume":"172","author":"Lamm","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2017.10.009_bb0445","doi-asserted-by":"crossref","first-page":"8862","DOI":"10.1038\/srep08862","article-title":"Hematologic and immunological characteristics of Henoch-Schonlein purpura in rat and rabbit models induced with ovalbumin based on type III hypersensitivity","volume":"5","author":"Li","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2017.10.009_bb0450","first-page":"4277","article-title":"Mechanism of feedback regulation of neutrophil inflammation in Henoch-Sch\u00f6nlein purpura","volume":"20","author":"Wu","year":"2016","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.autrev.2017.10.009_bb0455","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00403-016-1694-z","article-title":"Histopathological and immunological changes during the acute and recovery phase in Henoch-Schonlein purpura rabbit model","volume":"309","author":"Li","year":"2017","journal-title":"Arch Dermatol Res"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997217302598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997217302598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T01:13:02Z","timestamp":1693098782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997217302598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":91,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S1568997217302598"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2017.10.009","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New insights in the pathogenesis of immunoglobulin A vasculitis (Henoch-Sch\u00f6nlein purpura)","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2017.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}